February 2024 Publications
- MicroRNA-99b Regulates Bacillus Calmette-Guerin-Infected Immature Dendritic Cell-Induced CD4+ T Cell Differentiation by Targeting mTOR Signaling. Zhen L, Chen Y, Gao J, Li B, Jia Y. Crit Rev Immunol. 2024. doi: 10.1615/CritRevImmunol.2023050312.
- Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control. Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Powell Doherty R, Marshall JL, Cabrera Puig I, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. Lancet Infect Dis. 2024 Feb. doi: 10.1016/S1473-3099(23)00758-2.
- Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa. Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R, Scarponi D, Hatherill M, Menzies NA, White RG. Vaccine. 2024 Feb 1. doi: 10.1016/j.vaccine.2024.01.072.
- The potential for vaccines to aid the treatment of post-TB lung disease. Silva DR, Santos AP, Visca D, Bombarda S, Dalcolmo MMP, Galvão T, de Miranda SS, Parente AAAI, Rabah MF, de Sales RKB, Miglior GB, de Queiroz Mello FC. Int J Tuberc Lung Dis. 2024 Feb 1. doi: 10.5588/ijtld.23.0524.
- Development and application of the direct mycobacterial growth inhibition assay: a systematic review. Painter H, Harriss E, Fletcher HA, McShane H, Tanner R. Front Immunol. 2024 Feb 6. doi: 10.3389/fimmu.2024.1355983.
- IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model. Bradford SD, Ryan KJ, Divens AM, Povroznik JM, Bonigala S, Robinson CM. Front Immunol. 2024 Feb 8. doi: 10.3389/fimmu.2024.1217098.
- Impact of BCG vaccination disruptions during the COVID-19 pandemic on tuberculosis incidence in infants: a nationwide study in Brazil. Procianoy GS, Cotrim MW, Cia LO, Behar PRP. J Pediatric Infect Dis Soc. 2024 Feb 8. doi: 10.1093/jpids/piae013.
- Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery. Baydemir I, Dulfer EA, Netea MG, Domínguez-Andrés J. Clin Immunol. 2024 Feb 9. doi: 10.1016/j.clim.2024.109930.
- Exploring the immunogenicity of Rv2201-519: A T-cell epitope-based antigen derived from Mycobacterium tuberculosis AsnB with implications for tuberculosis infection detection and vaccine development. Luan X, Fan X, Li G, Li M, Li N, Yan Y, Zhao X, Liu H, Wan K. Int Immunopharmacol. 2024 Feb 10. doi: 10.1016/j.intimp.2024.111542.
- Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains. Painter H, Willcocks S, Zelmer A, Reljic R, Tanner R, Fletcher H. Tuberculosis (Edinb). 2024 Feb 13. doi: 10.1016/j.tube.2024.102494.
- Advances in understanding immune homeostasis in latent tuberculosis infection. Niu L, Wang H, Luo G, Zhou J, Hu Z, Yan B. WIREs Mech Dis. 2024 Feb 13. doi: 10.1002/wsbm.1643.
- Mtb HLA-E-tetramer-sorted CD8+ T cells have a diverse TCR repertoire. Voogd L, Drittij AMHF, Dingenouts CKE, Franken KLMC, Unen VV, van Meijgaarden KE, Ruibal P, Hagedoorn RS, Leitner JA, Steinberger P, Heemskerk MHM, Davis MM, Scriba TJ, Ottenhoff THM, Joosten SA. iScience. 2024 Feb 15. doi: 10.1016/j.isci.2024.109233.
- Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy. Alonso-Rodríguez N, Vianello E, van Veen S, Jenum S, Tonby K, van Riessen R, Lai X, Mortensen R, Ottenhoff THM, Dyrhol-Riise AM. Front Immunol. 2024 Feb 16. doi: 10.3389/fimmu.2024.1350593.
- Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains. Kwon KW, Choi HG, Choi HH, Choi E, Kim H, Kim HJ, Shin SJ. Vaccine. 2024 Feb 16. doi: 10.1016/j.vaccine.2024.02.039. Online ahead of print.
- Comparative transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium tuberculosis and Mycobacterium bovis BCG. Li P, Li Y, Wang CC, Xia LG. Microb Pathog. 2024 Feb 20. doi: 10.1016/j.micpath.2024.106593.
- Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol. Szachniewicz MM, Neustrup MA, van Meijgaarden KE, Jiskoot W, Bouwstra JA, Haks MC, Geluk A, Ottenhoff THM. Eur J Pharm Sci. 2024 Feb 20. doi: 10.1016/j.ejps.2024.106730.
- Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China. Tovar M, Sanz J, Moreno Y. Front Public Health. 2024 Feb 23. doi: 10.3389/fpubh.2024.1302688.
- From Antigens to Immune Responses: Shaping the Future of TB Detection and Prevention. Panda S, Kearns K, Cheng C, Arlehamn CSL. Int J Infect Dis. 2024 Feb 26. doi: 10.1016/j.ijid.2024.106983. Epub ahead of print.
- Perspectives on Development and Advancement of New Tuberculosis. da Costa C, Benn CS, Nyirenda T, Mpabalwani E, Grewal HMS, Ahmed R, Kapata N, Nyasulu PS, Maeurer M, Hui DS, Goletti D, Zumla A. Int J Infect Dis. 2024 Feb 26. doi: 10.1016/j.ijid.2024.106987. Online ahead of print.
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, Dos Santos G, de Lacerda MVG, Jardim BA, de Almeida E Val FF, Curtis N, Andrews JR, Croda J. Lancet Infect Dis. 2024 Feb 26. doi: 10.1016/S1473-3099(23)00818-6.
- Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection. Das S, Chauhan KS, Ahmed M, Akter S, Lu L, Colonna M, Khader SA. mBio. 2024 Feb 26. doi: 10.1128/mbio.03299-23. Epub ahead of print.
- BCG vaccination and multiple sclerosis risk: A Norwegian cohort study. Nakken O, Aarseth JH, Wergeland S, Stigum H, Meyer HE, Holmøy T. Mult Scler. 2024 Feb 27. doi: 10.1177/13524585241230440.
- Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021. Jackson S, Kabir Z, Comiskey C. Vaccine. 2024 Feb 28. doi: 10.1016/j.vaccine.2024.02.061.